228 related articles for article (PubMed ID: 22098699)
21. The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort.
Benhamou M; Rincheval N; Roy C; Foltz V; Rozenberg S; Sibilia J; Schaeverbeke T; Bourgeois P; Ravaud P; Fautrel B
J Rheumatol; 2009 May; 36(5):934-42. PubMed ID: 19286850
[TBL] [Abstract][Full Text] [Related]
22. Are rheumatologists' treatment decisions influenced by patients' age?
Fraenkel L; Rabidou N; Dhar R
Rheumatology (Oxford); 2006 Dec; 45(12):1555-7. PubMed ID: 16690762
[TBL] [Abstract][Full Text] [Related]
23. Control of rheumatoid arthritis with conventional disease-modifying antirheumatic drugs in a tertiary hospital in central South Africa.
Carter RMN; Jansen van Rensburg BJ; Joubert G
S Afr Med J; 2019 Dec; 110(1):27-31. PubMed ID: 31865939
[TBL] [Abstract][Full Text] [Related]
24. Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey.
Solomon DH; Ayanian JZ; Yelin E; Shaykevich T; Brookhart MA; Katz JN
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):184-9. PubMed ID: 22012868
[TBL] [Abstract][Full Text] [Related]
25. Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS).
Westhoff G; Schneider M; Raspe H; Zeidler H; Runge C; Volmer T; Zink A
Rheumatology (Oxford); 2009 Jun; 48(6):650-7. PubMed ID: 19321515
[TBL] [Abstract][Full Text] [Related]
26. Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational Study.
Michaud K; Pedro S; Wipfler K; Agarwal E; Katz P
Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1322-1331. PubMed ID: 33787086
[TBL] [Abstract][Full Text] [Related]
27. Patient's access to healthcare and treatment in rheumatoid arthritis: the views of stakeholders in Portugal.
Laires PA; Mesquita R; Veloso L; Martins AP; Cernadas R; Fonseca JE
BMC Musculoskelet Disord; 2013 Sep; 14():279. PubMed ID: 24067096
[TBL] [Abstract][Full Text] [Related]
28. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.
Pope JE; Hong P; Koehler BE
J Rheumatol; 2002 Feb; 29(2):255-60. PubMed ID: 11838842
[TBL] [Abstract][Full Text] [Related]
29. Delay in initiation of DMARD or anti-inflammatory therapy in patients newly diagnosed with rheumatoid arthritis: An analysis of United States Military Health System TRICARE beneficiaries.
Kimsey L; Weissman JS; Patel A; Drew A; Koehlmoos T; Sparks JA
Semin Arthritis Rheum; 2019 Apr; 48(5):821-827. PubMed ID: 30190154
[TBL] [Abstract][Full Text] [Related]
30. Update of French society for rheumatology recommendations for managing rheumatoid arthritis.
Daien C; Hua C; Gaujoux-Viala C; Cantagrel A; Dubremetz M; Dougados M; Fautrel B; Mariette X; Nayral N; Richez C; Saraux A; Thibaud G; Wendling D; Gossec L; Combe B
Joint Bone Spine; 2019 Mar; 86(2):135-150. PubMed ID: 30315988
[TBL] [Abstract][Full Text] [Related]
31. Treating early rheumatoid arthritis intensively: current UK practice does not reflect guidelines.
Garrood T; Shattles W; Scott DL
Clin Rheumatol; 2011 Jan; 30(1):103-6. PubMed ID: 20683739
[TBL] [Abstract][Full Text] [Related]
32. Practices for managing a flare of long-standing rheumatoid arthritis: survey among French rheumatologists.
Maravic M; Bergé C; Daurès JP; Boissier MC
Clin Exp Rheumatol; 2005; 23(1):36-42. PubMed ID: 15789885
[TBL] [Abstract][Full Text] [Related]
33. Predictors of stopping and starting disease-modifying antirheumatic drugs for rheumatoid arthritis.
Solomon DH; Tonner C; Lu B; Kim SC; Ayanian JZ; Brookhart MA; Katz JN; Yelin E
Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1152-8. PubMed ID: 24470443
[TBL] [Abstract][Full Text] [Related]
34. Care pathways in early rheumatoid arthritis.
Bernatsky S; Feldman D; Shrier I; Toupin K; Haggerty J; Tousignant P; Zummer M
Can Fam Physician; 2006 Nov; 52(11):1444-5. PubMed ID: 17279204
[TBL] [Abstract][Full Text] [Related]
35. A patient-centered knowledge translation tool for treat-to-target strategy in rheumatoid arthritis: Patient and rheumatologist perspectives.
Benham H; Chiu H; Tesiram J; Mehdi A; Landsberg P; Grosman S; Harrison A; Nash P; Thomas R; Langbecker D; Van Driel M
Int J Rheum Dis; 2021 Mar; 24(3):355-363. PubMed ID: 33470051
[TBL] [Abstract][Full Text] [Related]
36. Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study.
Kumar K; Raza K; Nightingale P; Horne R; Chapman S; Greenfield S; Gill P
BMC Musculoskelet Disord; 2015 Dec; 16():396. PubMed ID: 26714853
[TBL] [Abstract][Full Text] [Related]
37. Survey on management strategies of rheumatoid arthritis in Saudi Arabia: a Saudi Society for Rheumatology Initiative.
Omair MA; Omair MA; Halabi H
Int J Rheum Dis; 2017 Sep; 20(9):1185-1192. PubMed ID: 26354409
[TBL] [Abstract][Full Text] [Related]
38. Prescription rheumatology practices among Mexican specialists.
Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
[TBL] [Abstract][Full Text] [Related]
39. Provider Specialty and the Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among Older Adults in the 2005-2016 National Ambulatory Medical Care Survey.
Lee J; Chang CH; Yung R; Bynum JPW
ACR Open Rheumatol; 2022 Apr; 4(4):332-337. PubMed ID: 35040280
[TBL] [Abstract][Full Text] [Related]
40. Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspective.
Widdifield J; Bernatsky S; Paterson JM; Thorne JC; Cividino A; Pope J; Gunraj N; Bombardier C
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):53-7. PubMed ID: 20806274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
